By Matt Jones

NEW YORK (GenomeWeb News) – Researchers at Brigham and Women's Hospital and the University of Michigan School of Public Health will work with consumer genetics companies 23andMe and Pathway Genomics to study how consumers view, and are affected by, genetic tests and their results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.